| 14.28 0.45 (3.25%) | 03-27 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 17.91 |
1-year : | 20.92 |
| Resists | First : | 15.34 |
Second : | 17.91 |
| Pivot price | 13.74  |
|||
| Supports | First : | 13.59 |
Second : | 12.52 |
| MAs | MA(5) : | 13.45 |
MA(20) : | 14.05 |
| MA(100) : | 16.13 |
MA(250) : | 15.81 |
|
| MACD | MACD : | -0.5 |
Signal : | -0.5 |
| %K %D | K(14,3) : | 53.5 |
D(3) : | 35.6 |
| RSI | RSI(14): 51.5 |
|||
| 52-week | High : | 20.97 | Low : | 9.82 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ FTLF ] has closed below upper band by 30.8%. Bollinger Bands are 29.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 14.47 - 14.52 | 14.52 - 14.58 |
| Low: | 14.01 - 14.08 | 14.08 - 14.14 |
| Close: | 14.17 - 14.27 | 14.27 - 14.38 |
FitLife Brands, Inc. provides nutritional supplements for health-conscious consumers in the United States and internationally. It offers weight loss, general health, and sports nutrition supplements; precision sports nutrition formulations for professional muscular development; weight loss and sports nutrition performance enhancing supplements for fitness enthusiasts; and men's health and weight loss formulations, as well as other diet, health, and sports nutrition supplements and related products; and sports nutritional products, energy and weight loss products, and meal replacements. It markets its products under the brand names of NDS Nutrition, PMD Sports, SirenLabs, CoreActive, Metis Nutrition, iSatori, BioGenetic Laboratories, and Energize through franchised stores, as well as through various retail locations, including specialty, mass, and online. The company was formerly known as Bond Laboratories, Inc. and changed its name to FitLife Brands, Inc. in September 2013. FitLife Brands, Inc. was incorporated in 2005 and is headquartered in Omaha, Nebraska.
Tue, 17 Mar 2026
FitLife Brands Inc. (NASDAQ:FTLF) Short Interest Update - MarketBeat
Sun, 01 Mar 2026
Technical Reactions to FTLF Trends in Macro Strategies - Stock Traders Daily
Mon, 26 Jan 2026
FitLife: When Capital Allocation Matters More Than The Business (NASDAQ:FTLF) - Seeking Alpha
Thu, 20 Nov 2025
FitLife Brands’ Irwin Acquisition Might Not Be Fully Priced In (NASDAQ:FTLF) - Seeking Alpha
Thu, 13 Nov 2025
FitLife Brands Announces Third Quarter 2025 Results - globenewswire.com
Wed, 29 Oct 2025
Alluvial Capital Management’s Views on FitLife Brands (FTLF) - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Consumer Defensive
|
|
|
Industry:
Packaged Foods
|
|
| Shares Out | 9 (M) |
| Shares Float | 3 (M) |
| Held by Insiders | 15.1 (%) |
| Held by Institutions | 58.9 (%) |
| Shares Short | 79 (K) |
| Shares Short P.Month | 57 (K) |
| EPS | 0.68 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 4.46 |
| Profit Margin | 9.5 % |
| Operating Margin | 15 % |
| Return on Assets (ttm) | 9.6 % |
| Return on Equity (ttm) | 17.7 % |
| Qtrly Rev. Growth | 47 % |
| Gross Profit (p.s.) | 3.1 |
| Sales Per Share | 7.51 |
| EBITDA (p.s.) | 1.39 |
| Qtrly Earnings Growth | -57.1 % |
| Operating Cash Flow | 8 (M) |
| Levered Free Cash Flow | -1 (M) |
| PE Ratio | 21 |
| PEG Ratio | 0 |
| Price to Book value | 3.2 |
| Price to Sales | 1.9 |
| Price to Cash Flow | 16.45 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|